Patents

US 10519213 B2: Fusion proteins of collagen-binding domain and parathyroid hormone

Granted
2019-12-31
Filed
2019-07-22 application 16517988
Type
Utility · 13 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.

Source: PVGPATDIS, file of 2026-04-10 (ipg191231.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS 225 patentsUS company or organizationLittle Rock, ARPVGPATDIS, file of 2026-04-10
OCHSNER CLINIC FOUNDATION 9 patentsUS company or organizationNew Orleans, LAOCHSNER CLINIC FOUNDATION Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10
NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY 117 patentsForeign company or organizationSamukawa, JPPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Robert C. GensureLexington, MA11PVGPATDIS, file of 2026-04-10
Joshua SakonFayetteville, AR15PVGPATDIS, file of 2026-04-10
Osamu MatsushitaOkayama, JP14PVGPATDIS, file of 2026-04-10
Tulasi PonnapakkamMetairie, LA10PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/64PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K8/64PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P5/18PVGPATDIS, file of 2026-04-10
A61QSpecific use of cosmetics or similar toiletry preparationsA61Q7/00PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/635PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y205/01018PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2019-09-10Assignment
Assignment of assignor's interest
MATSUSHITA, OSAMU signed 2009-09-30NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY KAGAWA50329/254ECORSEXC, file of 2026-09-25
2019-09-10Assignment
Assignment of assignor's interest
GENSURE, ROBERT C. signed 2013-03-15
PONNAPAKKAM, TULASI signed 2013-03-15
OCHSNER CLINIC FOUNDATION NEW ORLEANS, LA50329/148ECORSEXC, file of 2026-09-25
2019-09-10Assignment
Assignment of assignor's interest
SAKON, JOSHUA signed 2009-09-30THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS LITTLE ROCK, AR50329/1ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.